Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)
China · Delayed Price · Currency is CNY 8.60
+0.03 (0.35%)
Feb 3, 2026, 11:30 AM CST
SHA:600867 Revenue
Tonghua Dongbao Pharmaceutical had revenue of 806.10M CNY in the quarter ending September 30, 2025, with 13.90% growth. This brings the company's revenue in the last twelve months to 2.74B, up 12.74% year-over-year. In the year 2024, Tonghua Dongbao Pharmaceutical had annual revenue of 2.01B, down -34.66%.
Revenue (ttm)
2.74B
Revenue Growth
+12.74%
P/S Ratio
6.08
Revenue / Employee
803.92K
Employees
3,410
Market Cap
16.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.01B | -1.07B | -34.66% |
| Dec 31, 2023 | 3.08B | 296.96M | 10.69% |
| Dec 31, 2022 | 2.78B | -489.44M | -14.98% |
| Dec 31, 2021 | 3.27B | 375.73M | 12.99% |
| Dec 31, 2020 | 2.89B | 115.02M | 4.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition